CD200 and myelodysplastic syndrome: After 36 months follow-up, we found that the CD200 positive expression and CTLA-4 concentration levels were significantly higher in dead MDS patients’ group as compared to those in the living group (P<0.01; P=0.01 respectively) (Table 4).